ZEB1 Regulates the Latent-Lytic Switch in Epstein-Barr Virus Infection
Author Information
Author(s): Yu Xianming Wang, Zhenxun Mertz, Janet E Mertz
Primary Institution: McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health
Hypothesis
How does ZEB1 influence the switch between latent and lytic infection in Epstein-Barr virus?
Conclusion
ZEB1 binding to the BZLF1 promoter is crucial for regulating the latent-lytic switch in Epstein-Barr virus, and mutations in this binding site can lead to spontaneous reactivation of the virus.
Supporting Evidence
- A 2-bp mutation in the ZEB1 binding site of the BZLF1 promoter led to spontaneous reactivation of the virus.
- ZEB1 binding is essential for maintaining the latent state of the virus in infected cells.
- Chemical inducers significantly increased virus production in cells infected with the ZEB1 mutant strain.
Takeaway
A small change in the virus's DNA can make it wake up from sleep and start making more virus, which could help in treating some cancers caused by this virus.
Methodology
The study involved creating a mutant strain of Epstein-Barr virus and observing its behavior in infected human cells.
Limitations
The study primarily focused on specific cell lines and may not fully represent all types of cells infected by Epstein-Barr virus.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website